ShockWave Medical, Inc. (SWAV) Stock Overview
Explore ShockWave Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
ShockWave Medical, Inc. (SWAV)
Key Financials
Key Financials
Market Cap
12.6B
P/E Ratio
83.48
EPS (TTM)
$4.25
ROE
0.25%
SWAV Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of ShockWave Medical, Inc. (NASDAQ: SWAV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, ShockWave Medical, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SWAV on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $421.27 for the NASDAQ listing.
Key metrics behind ShockWave Medical, Inc.'s NASDAQ-traded stock include a P/E ratio of 83.48 and a market capitalization of 12.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SWAV on the NASDAQ.